RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857
Pharmaceuticals issued a retraction of https://doi.org/10.3390/ph15070857 (source: publisher).